Want to see PMVP full AI Analyst Report?
PMV Pharmaceuticals (PMVP) Income Statement
PMV Pharmaceuticals Income Statement
Last quarter (Q2 2026), PMV Pharmaceuticals's total revenue was $0.00. In Q2, PMV Pharmaceuticals's net income was $-18.09M. See PMV Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -1.14M | $ -1.26M | $ -650.00K | $ -1.28M | |
| $ 86.21M | $ 84.30M | $ 78.88M | $ 76.39M | $ 57.01M | |
| Depreciation and Amortization | $ 133.00K | $ 1.14M | $ 1.26M | $ 315.00K | $ 307.00K |
| $ -79.78M | $ -73.67M | $ -67.70M | $ -73.01M | $ -57.52M | |
| $ -86.21M | $ -85.45M | $ -80.13M | $ -77.04M | $ -58.29M | |
| $ 6.29M | $ 10.64M | $ 11.17M | $ 3.71M | $ 470.00K | |
| $ -79.91M | $ -74.81M | $ -68.96M | $ -73.33M | $ -57.82M | |
| $ -77.74M | $ -58.71M | $ -68.96M | $ -73.32M | $ -57.85M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.48 | $ -1.14 | $ -1.44 | $ -1.61 | $ -1.28 |
| Diluted EPS | $ -1.48 | $ -1.14 | $ -1.44 | $ -1.61 | $ -1.28 |
| Weighted Average Shares Outstanding | 52.54M | 51.58M | 48.01M | 45.59M | 45.14M |
| Weighted Average Shares Outstanding (Diluted) | 52.54M | 51.58M | 48.01M | 45.59M | 45.14M |
Currency in USD
